Insulin resistance in type 2 diabetic youth

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 4, 2012, Pages 255-262

  Mizokami Stout, Kara ^a   Cree Green, Melanie ^a   Nadeau, Kristen J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Impaired glucose tolerance; Insulin resistance; Pediatric; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLIMEPIRIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADOLESCENT; AUTOIMMUNITY; BODY COMPOSITION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOPULMONARY FUNCTION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; JUVENILE; LIFESPAN; LIFESTYLE MODIFICATION; MENSTRUAL CYCLE; MICROALBUMINURIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; REVIEW; SIDE EFFECT; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ADOLESCENT; BODY MASS INDEX; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 2; EXERCISE TOLERANCE; FEMALE; GLUCAGON; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; METFORMIN; OBESITY; PHENOTYPE; YOUNG ADULT;

EID: 84864626176     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283557cd5     Document Type: Review

References (92)

1. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is 'syndrome X' present? J Clin Endocrinol Metab 1996; 81:1058-1062.
2. D'Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabet Care 2011; 34 (Suppl 2):S161-S165.
3. Ogden C, Carroll M, Kit B, Flegal K. Prevalence of obesity in the United States, 2009-2010. NCHS data brief, no 82, January 2012; pp. 1-8.
4. Hyattsville, MD: National Center for Health Statistics, http://www.cdc.gov/nchs/data/databriefs/db82.htm. [Accessed 15 May 2012].
5. Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010; 95:5189-5198.
6. Lee S, Bacha F, Gungor N, Arslanian S. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 2008; 152:177-184.
7. Sinaiko AR, Steinberger J, Moran A, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005; 111:1985-1991.
8. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141:1249-1253.
9. Nadeau KJ, Zeitler PS, Bauer TA, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab 2009; 94:3687-3695.
10. Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32:335-341.
11. Jeffery AN, Metcalf BS, Hosking J, et al. Age Before Stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care 2012; 35:536-541.
12. Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004; 89:1096-1101.
13. Henderson M, Rabasa-Lhoret R, Bastard JP, et al. Measuring insulin sensitivity in youth: how do the different indices compare with the gold-standard method? Diabet Metab 2011; 37:72-78.
14. Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus-positive patients. Diabetes 2009; 58:738-744.
15. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabet Care 2000; 23:295-301.
16. George L, Bacha F, Lee S, et al. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab 2011; 96:2136-2145.
17. Schwartz B, Jacobs DR Jr, Moran A, et al. Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabet Care 2008; 31:783-788.
18. Aradillas-Garcia C, Rodriguez-Moran M, Garay-Sevilla ME, et al. Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents. Eur J Endocrinol 2012; 166:301-306.
19. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139:802-809.
20. Dabelea D, D'Agostino RB Jr, Mason CC, et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2010; 54:78-86.
21. Pacini G. The hyperbolic equilibrium between insulin sensitivity and secretion. Nutrition, metabolism, and cardiovascular diseases: NMCD 2006; 16 (Suppl 1):S22-S27.
22. Lyssenko V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005; 54:166-174.
23. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabet Care 2007; 30:1544-1548.
24. Sjaarda LG, Bacha F, Lee S, et al. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr 2012. [Epub ahead of print]
25. Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009; 58:773-795.
26. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-846.
27. Brufani C, Ciampalini P, Grossi A, et al. Glucose tolerance status in 510 children and adolescents attending an obesity clinic in central Italy. Pediatr Diabetes 2010; 11:47-54.
28. Cali AM, Man CD, Cobelli C, et al. Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabet Care 2009; 32:456-461.
29. Taha D, Umpaichitra V, Banerji MA, Castells S. Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance. J Pediatr Endocrinol Metab 2006; 19:135-142.
30. Burns SF, Bacha F, Lee SJ, et al. Declining beta-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabet Care 2011; 34:2033-2040
31. Tfayli H, Lee SJ, Bacha F, Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about beta-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes 2011; 12:572-579
32. Weiss R, Caprio S, Trombetta M, et al. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005; 54:1735-1743.
33. Giannini C, Weiss R, Cali A, et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes 2012; 61:606-614.
34. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359:2220-2232.
35. Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care 2011; 34 (Suppl 2):S166-S170.
36. Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004; 144:656-659.
37. Kleber M, Lass N, Papcke S, et al. One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med 2010; 27:516-521.
38. Smith RJ, Nathan DM, Arslanian SA, et al. Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know. J Clin Endocrinol Metab 2010; 95:1566-1574.
39. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007; 369:1823-1831.
40. Weiss R, Taksali SE, Tamborlane WV, et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005; 28:902-909.
41. Kleber M, deSousa G, Papcke S, et al. Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 2011; 119:172-176
42. Nowicka P, Santoro N, Liu H, et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 2011; 34:1306-1311.
43. Zeitler P. Update on nonautoimmune diabetes in children. J Clin Endocrinol Metab 2009; 94:2215-2220.
44. Cali AM, Bonadonna RC, Trombetta M, et al. Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. J Clin Endocrinol Metab 2008; 93:1767-1773.
45. Weiss R, D'Adamo E, Santoro N, et al. Basal alpha-cell up-regulation in obese insulin-resistant adolescents. J Clin Endocrinol Metab 2011; 96:91-97.
46. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005; 146:693-700.
47. Dabelea D, Bell RA, D'Agostino RB Jr, et al. Incidence of diabetes in youth in the United States. JAMA 2007; 297:2716-2724.
48. Mayer-Davis EJ, Bell RA, Dabelea D, et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009; 32 (Suppl 2):S99-S101.
49. Vukovic R, Mitrovic K, Milenkovic T, et al. Type 2 diabetes mellitus and impaired glucose regulation in overweight and obese children and adolescents living in Serbia. Int J Obes (Lond) 2012. [Epub ahead of print].
50. Urakami T, Morimoto S, Nitadori Y, et al. Urine glucose screening program at schools in Japan to detect children with diabetes and its outcome-incidence and clinical characteristics of childhood type 2 diabetes in Japan. Pediatric research 2007; 61:141-145.
51. Lee JM, Okumura MJ, Davis MM, et al. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006; 29:2427-2432.
52. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33(Suppl 1):S62-S69.
53. Lee JM, Gebremariam A, Wu EL, et al. Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care 2011; 34:2597-2602.
54. Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics 2009; 124:573-579.
55. Lee HS, Park HK, Hwang JS. HbA(1c) and glucose intolerance in obese children and adolescents. Diabet Med 2012. [Epub ahead of print].
56. Greig F, Hyman S, Wallach E, et al. Which obese youth are at increased risk for type 2 diabetes? Latent class analysis and comparison with diabetic youth. Pediatr Diabetes 2012; 13:181-188.
57. Bahillo-Curieses MP, Hermoso-Lopez F, Martinez-Sopena MJ, et al. Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents. Endocrine 2012; 41:289-295.
58. Maffeis C, Pinelli L, Brambilla P, et al. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 2010; 18:1437-1442.
59. Garnett SP, Srinivasan S, Birt SG, et al. Evaluation of glycaemic status in young people with clinical insulin resistance; fasting glucose, fasting insulin or an oral glucose tolerance test? Clin Endocrinol (Oxf) 2010; 72:475-480.
60. Libman IM, Barinas-Mitchell E, Bartucci A, et al. Reproducibility of the oral glucose tolerance test in overweight children. J Clin Endocrinol Metab 2008; 93:4231-4237.
61. Tsay J, Pomeranz C, Hassoun A, et al. Screening markers of impaired glucose tolerance in the obese pediatric population. Horm Res Paediatr 2010; 73:102-107.
62. Morrison KM, Xu L, Tarnopolsky M, et al. Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 2012; 35:711-716.
63. Kim G, Caprio S. Diabetes and insulin resistance in pediatric obesity. Pediatr Clin N Am 2011; 58:1355-1361.
64. Low JC, Felner EI, Muir AB, et al. Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes? Primary care diabetes 2012; 6:61-65.
65. Dabelea D, Pihoker C, Talton JW, et al. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care 2011; 34:1628-1633.
66. Klingensmith GJ, Pyle L, Arslanian S, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010; 33:1970-1975.
67. Nadeau K, Regensteiner J, Bauer JG, et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 2010; 95:513-521.
68. Bacha F, Pyle L, Nadeau K, et al. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes 2012. [Epub ahead of print].
69. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab 2002; 15 (Suppl 2):737-744.
70. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 2000; 13 (Suppl 6):1395-1402.
71. Urakami T, Habu M, Kuwabara R, et al. Insulin resistance at diagnosis in Japanese children with type 2 diabetes mellitus. Pediatrics international: official journal of the Japan Pediatric Society 2012. [Epub ahead of print].
72. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003; 362:951-957.
73. Nadeau KJ, Klingensmith G, Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr 2005; 41:94-98.
74. Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of nonalcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes 2009; 10:5-13.
75. Perseghin G, Bonfanti R, Magni S, et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006; 291:E697-E703.
76. Wittmeier KD, Wicklow BA, Macintosh AC, et al. Hepatic Steatosis and Low Cardiorespiratory Fitness in Youth With Type 2 Diabetes. Obesity (Silver Spring) 2012; 20:1034-1040.
77. Gusso S, Hofman P, Lalande S, et al. Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia 2008; 51:1317-1320.
78. Hannon TS, Lee S, Chakravorty S, et al. Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance. Int J Pediatr Obes 2011; 6:157-160.
79. Johnson ST, Newton AS, Chopra M, et al. In search of quality evidence for lifestyle management and glycemic control in children and adolescents with type 2 diabetes: a systematic review. BMC Pediatr 2010; 10:97.
80. Fleischman A, Rhodes ET. Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy. Diabetes metabolic syndrome and obesity: targets and therapy 2009; 2:185-202.
81. Savoye M, Nowicka P, Shaw M, et al. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics 2011; 127:402-410.
82. Carrel AL, Clark RR, Peterson SE, et al. Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program: a randomized, controlled study. Arch Pediatr Adolesc Med 2005; 159:963-968.
83. Ferguson MA, Gutin B, Le NA, et al. Effects of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int J Obes Relat Metab Disord 1999; 23:889-895.
84. Allen DB, Nemeth BA, Clark RR, et al. Fitness is a stronger predictor of fasting insulin levels than fatness in overweight male middle-school children. J Pediatr 2007; 150:383-387.
85. Brotman LM, Dawson-McClure S, Huang KY, et al. Early childhood family intervention and long-term obesity prevention among high-risk minority youth. Pediatrics 2012; 129:e621-e628.
86. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. TODAY Study Group 2012. [Epub ahead of print]. doi: 10.1056/NEJMoa1109333.
87. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25:89-94.
88. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, singleblind comparative study. Diabetes Care 2007; 30:790-794.
89. Zuhri-Yafi MI, Brosnan PG, Hardin DS. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2002; 15 (Suppl 1): 541-546.
90. Gemmill JA, Brown RJ, Nandagopal R, et al. Clinical trials in youth with type 2 diabetes. Pediatr Diabetes 2011; 12:50-57.
91. Cali AM, Pierpont BM, Taksali SE, et al. Rosiglitazone improves glucose metabolism in obese adolescents with impaired glucose tolerance: a pilot study. Obesity 2011; 19:94-99
92. Rhodes ET, Prosser LA, Hoerger TJ, et al. Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus. Diabet Med 2011; 29:453-463.